Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2028

Conditions

MDSAML, Adult

Interventions

DRUG

selinexor in combination with venetoclax

After allo-HSCT, intermediate-high risk MDS/AML patients are maintenanced with selinexor given in combination with venetoclax for 2 years

Trial Locations (1)

Ruijin Hospital of Shanghai Jiaotong University, Shanghai

All Listed Sponsors

lead

Ruijin Hospital

OTHER